ArticleMolecular oncology2025

Multi-omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine.

Livia Concetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.